Drugs / BILN 2061 W
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02226952 | Nov 2001 → Apr 2002 | chronic hepatitis C virus infection | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BILN 2061 W | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02226952 ↗ |